Phenyliodine(III) Bis(Trifluoroacetate) Mediated Synthesis of 2‐Aryl‐1,2‐Benzisothiazol‐3(2H)‐Ones in Ionic Liquid

Treatment of N‐aryl‐2‐(benzylthio)benzamides with phenyliodine(III) bis(trifluoroacetate) containing trifluoroacetic acid resulted in an interrupted Pummerer‐type reaction in ionic liquid 1‐n‐butyl‐3‐methylimidazolium hexafluorophosphate, [bmim][PF₆] to give 2‐aryl‐1,2‐benzisothiazol‐3(2H)‐ones rather than the normal Pummerer‐type products.     

Ene Reaction with Pummerer‐type Reaction Intermediate of α‐(Methylthio)‐N‐methoxy‐N‐methyl Acetamide: A New Synthesis of N‐methoxy‐N‐methyl‐(E,E)‐2,4‐dienamides

Pummerer‐type reaction intermediate 2 of α‐(methylthio)‐N‐methoxy‐N‐methyl acetamide (1) has been found to react with 1‐alkenes to afford ene adducts 3 . N‐Methoxy‐N‐methyl‐(E,E)‐2,4‐dienamides were synthesized from the adducts 3b‐f .     

Ionic Liqids in Organic Synthesis: The Pummerer Reaction

Pummerer‐type reaction was carried out with α‐acyl sulfides and phenyliodine(III) bis(trifluoroacetate) (PIFA) instead of α‐acyl sulfoxides in the room temperature ionic liquid 1‐n‐butyl‐3‐methylimidazolium hexafluorophosphate [bmim][PF₆] under mild conditions to give the ene adducts 3 in good yields.     

Bis(4,4′‐dimethyl‐2,2′‐bipyridine) ruthenium (II) Complexes Containing 2‐Arylimidazo‐ [4,5‐f] [1,10] phenanthroline: Syntheses,Characterization and Third‐order Nonlinear Optical Properties

Four novel mononuclear ruthenium(II) complexes [Ru(dmb)₂L]²⁺ [dmb = 4,4′‐dimethyl‐2,2′‐bipyridine, L = imidazo‐[4,5‐f][1,10]phenanthroline (IP), 2‐phenylimidazo‐[4,5‐f][1,10]phenanthroline (PIP), 2‐(4′‐hydroxyphenyl)imidazo‐[4,5‐f] [1,10] phenanthroline (HOP), 2‐(4′‐dimethylaminophenyl) imidazo‐[4, 5‐f] [1,10] phenanthroline (DMNP)] were synthesized and characterized by ES‐MS, ¹H NMR, UV‐vis and electrochemistry. The nonlinear optical properties of the ruthenium(II) complexes were investigated by Z‐scan techniques with 12 ns laser pulse at 540 nm, and all of them exhibit both nonlinear optical (NLO) absorption and self‐defocusing effect. The corresponding effective NLO susceptibility |x³| of the complexes is in the range of 2.68 × 10^?12‐4.57 × 10^?12 esu.     

A Facile Synthesis of Oxoindenothiazine and Dioxospiro(indene‐2,4′‐thiazine) Derivatives from (Substituted ethylidene)hydrazinecarbothioamides

(E)‐2‐[2‐(1‐Substituted ethylidene)hydrazinyl]‐5‐oxo‐9b‐hydroxy‐5,9b‐dihydroindeno[1,2‐d][1,3]‐thiazine‐4‐carbonitriles and (E)‐5‐oxo‐[(E)‐(1‐substituted ethylidene)hydrazinyl]‐2,5‐dihydroindeno[1,2‐d][1,3]thiazine‐4‐carbonitriles have been obtained from the reaction of 2‐(substituted ethylidene)hydrazinecarbothioamides with 2‐(1,3‐dioxo‐2,3‐dihydro‐1H‐inden‐2‐ylidene)propanedinitrile ( 1 ) in ethyl acetate solution. However, (Z)‐6′‐amino‐1,3‐dioxo‐3′‐substituted‐2′‐[(E)‐(1‐phenylethylidene)hydrazono]‐1,2′,3,3′‐tetrahydrospiro(indene‐2,4′‐[1,3]thiazine)‐5′‐carbonitriles were observed during the reaction of N‐substituted‐2‐(1‐phenylethylidene)hydrazinecarbothioamides with ( 1 ). The structure assignment of products has been confirmed on the basis of ¹H‐, ¹³C‐NMR, and mass spectrometry, as well as theoretical calculations.     

Conformational Studies of (±)‐11,12‐Didehydro‐11‐deoxycorynoline and (+)‐11,13‐Didehydro‐11‐deoxychelidonine,Hexahydrobenzo[c]phenanthridine‐Type Alkaloid Derivatives,by X‐Ray Crystal Structure and NMR Analyses

The X‐ray crystal analyses of the two 11‐deoxy‐didehydrohexahydrobenzo[c]phenanthridine‐type alkaloid derivatives 3 and 4 , derived from (±)‐corynoline ( 1 ) and (+)‐chelidonine ( 2 ), established their structures as (±)‐(5bRS,12bRS)‐5b,12b,13,14‐tetrahydro‐5b,13‐dimethyl[1,3]benzodioxolo[5,6‐c]‐1,3‐dioxolo[4,5‐i]phenanthridine ( 3 ) and (+)‐rel‐(12bR)‐7,12b,13,14‐tetrahydro‐13‐methyl[1,3]benzodioxolo[5,6‐c]‐1,3‐dioxolo[4,5‐i]phenanthridine ( 4 ). The conformations of 3 and 4 in CDCl₃ were determined on the basis of ¹H‐ and ¹³C‐NMR spectroscopy.     

Structural comparison of group 7 tricarbonyl complexes of 2‐{[2‐(1H‐imidazol‐4‐yl)ethyl]iminomethyl}‐5‐methylphenolate

Two tricarbonyl complexes of rhenium(I) and manganese(I) coordinated by the ligand 2‐{[2‐(1H‐imidazol‐4‐yl)ethyl]iminomethyl}‐5‐methylphenolate are reported, viz. fac‐tricarbonyl(2‐{[2‐(1H‐imidazol‐4‐yl‐κN³)ethyl]iminomethyl‐κN}‐5‐methylphenolato‐κO)rhenium(I) methanol monosolvate, [Re(C₁₆H₁₄N₃O₄)(CO)₃]·CH₃OH, (I), and fac‐tricarbonyl(2‐{[2‐(1H‐imidazol‐4‐yl‐κN³)ethyl]iminomethyl‐κN}‐5‐methylphenolato‐κO)manganese(I), fac‐[Mn(C₁₆H₁₄N₃O₄)(CO)₃], (II), display facial coordination in a distorted octahedral environment. The crystal structure of (I) is stabilized by O—H...O, N—H...O and C—H...O hydrogen‐bond interactions, while that of (II) is stabilized by N—H...O hydrogen‐bond interactions only. These interactions result in two‐dimensional networks and π–π stacking for both structures.     

Dimerization of Dimethyl 2‐(Naphthalen‐1‐yl)cyclopropane‐1,1‐dicarboxylate in the Presence of GaCl3 to [3+2], [3+3], [3+4], and Spiroannulation Products

In the presence of a catalytic amount of GaCl₃, dimethyl 2‐(naphthalen‐1‐yl)cyclopropane‐1,1‐dicarboxylate 5 undergoes selective [3+2]‐annulation‐type dimerization to give a polysubstituted cyclopentane containing two naphthalenyl substituents in the vicinal position (Scheme 2). Treatment of the same cyclopropane with an equimolar amount of GaCl₃?THF results in dimerization with electrophilic attack on each of the benzene rings to give [3+3] and [3+4] annulation products. The latter represent a new type of dimerization of donor? acceptor cyclopropanes. Finally, under conditions of double catalysis with GaCl₃, 3,3,5,5‐tetrasubstituted 4,5‐dihydropyrazole, this cyclopropane‐dicarboxylate undergoes stereospecific dimerization as a result of electrophilic ipso‐attack to give a tetracyclic pentaleno[6a,1‐a]naphthalene derivative (Scheme 5). Possible reaction mechanisms are proposed.     

Efficient Synthesis of (3E)‐3‐[Amino(aryl)methylidene]chromane‐2,4‐diones (=(3E)‐3‐[Amino(aryl)methylene]‐2H‐1‐benzopyran‐2,4(3H)‐diones) via a Three‐Component Reaction

The Michael‐type addition of a 4‐hydroxycoumarin (=4‐hydroxy‐2H‐1‐benzopyran‐2‐one) 1 to a β‐nitrostyrene (=(2‐nitroethenyl)benzene) 2 in the presence of AcONH₄ leads to substituted (3E)‐3‐[amino(aryl)methylidene]chroman‐2,4‐diones (=(3E)‐3‐[amino(aryl)methylene]‐2H‐1‐benzopyran‐2,4(3H)‐diones) 4 (Table 1). High yields, short reaction time, and easy workup are advantages of this novel one‐pot three‐component reaction.     

Facile Chemoselective synthesis of 2‐(2‐(Methoxycarbonyl)‐3‐oxo‐2,3‐dihydrobenzofuran‐2‐yl)benzoic acids and 3H,3’H‐Spiro[benzofuran‐2,1′‐isobenzofuran]‐3,3′‐dione derivatives

Oxidation of some derivatives of 4b,9b–dihydroxyindeno[1,2‐b]benzofuran‐10‐one have been investigated in detail using lead(IV) acetate in acetic acid under reflux conditions and periodic acid in aqueous ethanol at room temperature. We realized that during the first 5–15 minutes of the oxidation reactions in lead(IV) acetate/acetic acid system, 3H,3’H‐spiro[benzofuran‐2,1′‐isobenzofuran]‐3,3′‐dione derivatives have been synthesized chemo selectively, while, if the reaction mixtures stirred for additional 3 hours, the main products would be 2‐(2‐(Methoxycarbonyl)‐3‐oxo‐2,3‐dihydrobenzofuran‐2‐yl)benzoic acids. Moreover, room temperature oxidation of 4b,9b–dihydroxyindeno[1,2‐b]benzofuran‐10‐ones by periodic acid (H₅IO₆), leads to the formation of 3H,3’H‐spiro[benzofuran‐2,1′‐isobenzofuran]‐3,3′‐dione derivatives in good to excellent yields.     

Synthesis,spectroscopic, thermal and biological aspects of drug‐based copper(II) complexes

A series of novel complexes of the type Cu(II)(L_n)₂(H₂O)₂]^•xH₂O [where L_n = L _1–4 , these ligands being described as: L ₁ , 2‐({4‐[6,7‐dihydrothieno[3,2‐c]pyridin‐5(4H)‐ylsulfonyl]phenylimino}methyl)phenol, x = 1; L ₂ , 2‐({4‐[6,7‐dihydrothieno[3,2‐c] pyridin‐5(4H)‐ylsulfonyl]phenylimino}methyl)‐5‐(methoxy)phenol, x = 2; L ₃ , 5‐chloro‐2‐({4‐[6,7‐dihydrothieno[3,2‐c]pyridin‐5(4H)‐ylsulfonyl]phenylimino}methyl)phenol, x = 2; and L ₄ , 5‐bromo‐4‐chloro‐2‐({4‐[6,7‐dihydrothieno[3,2‐c]pyridin‐5(4H)‐ylsulfonyl]phenylimino} methyl)phenol, x = 1] was investigated. They were characterized by elemental analysis, IR, ¹H‐NMR, ¹³C‐NMR and electronic spectra, magnetic measurements and thermal studies. The FAB‐mass spectrum of [Cu(II)( L ₁ )₂(H₂O)₂]^•H₂O was determined. A magnetic moment and reflectance spectral study revealed that an octahedral geometry could be assigned to all the prepared complexes. Ligands (L_n) and their metal complexes were screened for their in vitro antibacterial activity against Bacillus subtillis, Pseudomonas aeruginosa, Escherichia coli and Serratia marcescens bacterial strains. Kinetic parameters such as order of reaction (n), the energy of activation (E_a), the pre‐exponential factor (A), the activation entropy (ΔS^≠), the activation enthalpy (ΔH^≠) and the free energy of activation (ΔG^≠) are reported. Copyright © 2011 John Wiley & Sons, Ltd.     

Synthesis,crystal structure and activity evaluation of novel 3,4‐dihydro‐1‐benzoxepin‐5(2H)‐one derivatives as protein–tyrosine kinase (PTK) inhibitors

Four new 3,4‐dihydro‐1‐benzoxepin‐5(2H )‐one derivatives, namely (E )‐4‐(5‐bromo‐2‐hydroxybenzylidene)‐6,8‐dimethoxy‐3,4‐dihydrobenzo[b ]oxepin‐5(2H )‐one, ( 7 ), (E )‐4‐[(E )‐3‐(5‐bromo‐2‐hydroxyphenyl)allylidene]‐6,8‐dimethoxy‐3,4‐dihydrobenzo[b ]oxepin‐5(2H )‐one, ( 8 ), (E )‐4‐(5‐bromo‐2‐hydroxybenzylidene)‐6‐hydroxy‐8‐methoxy‐3,4‐dihydrobenzo[b ]oxepin‐5(2H )‐one, C₁₈H₁₅BrO₅, ( 9 ), and (E )‐4‐[(E )‐3‐(5‐bromo‐2‐hydroxyphenyl)allylidene]‐6‐hydroxy‐8‐methoxy‐3,4‐dihydrobenzo[b ]oxepin‐5(2H )‐one, ( 10 ), have been synthesized and characterized by FT–IR, NMR and MS. The structure of ( 9 ) was confirmed by single‐crystal X‐ray diffraction. Crystal structure analysis shows that molecules of ( 9 ) are connected into a one‐dimensional chain in the [010] direction through classical hydrogen bonds and these chains are further extended into a three‐dimensional network via C—H…O interactions. The inhibitory activities of these compounds against protein–tyrosine kinases (PTKs) show that 6‐hydroxy‐substituted compounds ( 9 ) and ( 10 ) are more effective for inhibiting ErbB1 and ErbB2 than are 6‐methoxy‐substituted compounds ( 7 ) and ( 8 ). This may be because ( 9 ) and ( 10 ) could effectively bind to the active pockets of the protein through intermolecular interactions.     

`0'‐ and `8'‐shaped complexes generated from a nano‐sized oxadiazole‐containing organic ligand with CdI2 and CuI

A new nano‐sized rigid double‐armed oxadiazole‐bridged organic ligand, 2,5‐bis{2‐methyl‐5‐[2‐(pyridin‐3‐yl)ethenyl]phenyl}‐1,3,4‐oxadiazole, C₃₀H₂₀N₄O, L or (I), which adopts a cis conformation in the solid state, has been synthesized and used to create the two novel metallocycle complexes (2,5‐bis{2‐methyl‐5‐[2‐(pyridin‐3‐yl‐κN)ethenyl]phenyl}‐1,3,4‐oxadiazole)diiodidocadmium(II) dichloromethane monosolvate, [CdI₂(C₃₀H₂₀N₄O)]·CH₂Cl₂, (II), and di‐μ‐iodido‐bis[(2,5‐bis{2‐methyl‐5‐[2‐(pyridin‐3‐yl‐κN)ethenyl]phenyl}‐1,3,4‐oxadiazole)copper(I)], [Cu₂I₂(C₃₀H₂₀N₄O)₂], (III). Molecules of complex (II) adopts a 20‐membered `0'‐shaped metallocycle structure with crystallographic mirror symmetry. The discrete units are linked into one‐dimensional chains through intermolecular π–π and C—H...π interactions. In (III), the two I atoms and two Cu<sup>I</sup> atoms form a {Cu<sub>2</sub>(μ‐I)<sub>2</sub>} cluster. One {Cu<sub>2</sub>(μ‐I)<sub>2</sub>} cluster and two L ligands form two 20‐membered monometallic rings in a head‐to‐head fashion, leading to a discrete centrosymmetric `8'‐shaped metallocyclic complex. These metallocycles stack together via two kinds of intermolecular π–π interactions to generate a two‐dimensional network in the ac plane. The luminescence properties of (I)–(III) were investigated in the solid state at room temperature and displayed an obvious red shift.     

Synthesis of 4‐((2‐hydroxynaphthalen‐1‐yl)(aryl)methyl)‐5‐methyl‐2‐phenyl‐1H‐pyrazol‐3(2H)‐ones using nano‐Zn‐[2‐boromophenyl‐salicylaldimine‐methylpyranopyrazole]Cl2 nanoparticles

Nano‐Zn‐[2‐boromophenyl‐salicylaldimine‐methylpyranopyrazole]Cl₂ (nano‐[Zn‐2BSMP]Cl₂) as a nanoparticle Schiff base complex and a catalyst was introduced for the solvent‐free synthesis of 4‐((2‐hydroxynaphthalen‐1‐yl)(aryl)methyl)‐5‐methyl‐2‐phenyl‐1H‐pyrazol‐3(2H)‐ones by the multicomponent condensation reaction of various aromatic aldehydes, β‐naphthol, ethyl acetoacetate, and phenyl hydrazine at room temperature.     

Manganese(III) Acetate Catalyzed Oxidative Radical Additions of α‐Dicarbonyl Compounds to 1‐ and 2‐Phenylcyclohepta‐1,3,5‐triene

Manganese(III) acetate catalyzed oxidative radical‐addition reactions of α‐dicarbonyl compounds such as methyl acetoacetate ( 6 ), acetylacetone ( 7 ), and dimedone ( 8 ) to the mixture of 1‐ and 2‐phenylcyclohepta‐1,3,5‐triene ( 4 and 5 ) were investigated (Scheme 1). The 1‐phenylcyclohepta‐1,3,5‐triene ( 4 ) formed mainly [2+3] and [4+3] dihydrofuran addition products derived from cycloheptatriene and [2+3] dihydrofuran addition products derived from the norcaradiene structure. The 2‐phenylcyclohepta‐1,3,5‐triene ( 5 ) formed mainly [6+3] dihydrofuran addition products derived from cycloheptatriene and [4+3] dihydrofuran addition products derived from the norcaradiene structure. The structures of isolated products were established by their spectroscopic data (IR, ¹H‐ and ¹³C‐NMR, MS, and elemental analysis) and comparison with literature data. The formation mechanism of the products is discussed.     

Hydroaluminierung: Synthese,Struktur und Eigenschaften von 1‐Methyl‐cis‐1‐azonia‐5‐alabicyclo[3.3.0]octan und des Alan‐triallylamin‐Adduktes

Hydro‐Alumination: Synthesis, Structure, and Properties of 1‐Methyl‐ cis ‐1‐azonia‐5‐alabicyclo[3.3.0]octane and of the Alan‐triallylamine Adduct The alan‐N‐methyl‐diallylamine adduct ( I ) was obtained by the reaction of N,N‐diallyl‐methyl‐ammoniumchloride with LiAlH₄. Subsequently the reaction product was transformed by intramolecular hydro‐alumination reaction into bis(1‐methyl‐cis‐1‐azonia‐5‐alabicyclo[3.3.0]octane) ( II ). In contrast to I , the bis(alan‐triallylamine) adduct ( III ) does not undergo an analogous hydro‐alumination reaction. The compounds I , II and III were characterized by MS, IR, ¹H‐, ¹³C‐ and ²⁷Al‐NMR spectroscopy, and the X‐ray structures of II and III are reported and discussed.     

New Aspects of 1,3‐Diphosphacyclobutane‐2,4‐diyls

1,3‐Di(tert‐butyl)‐2,4‐bis[2,4,6‐tri(tert‐butyl)phenyl]‐1,3‐diphosphacyclobutane‐2,4‐diyl was formed from [2,4,6‐tri(tert‐butyl)phenyl]phosphaacetylene and t‐BuLi. In addition, the X‐ray diffraction analysis was carried out, together with theoretical calculations of the structure and NMR data.     

Synthesis and coordination chemistry of the PPN ligand 2‐[bis(diisopropylphosphanyl)methyl]‐6‐methylpyridine

The synthesis and crystal structure of the multidentate PPN ligand 2‐[bis(diisopropylphosphanyl)methyl]‐6‐methylpyridine (L ), C₁₉H₃₅NP₂, are described. In the isostructural tetrahedral Fe and Co complexes of type LM Cl₂ (M = Fe, Co), namely {2‐[bis(diisopropylphosphanyl)methyl]‐6‐methylpyridine‐κ²P ,N }dichloridoiron(II), [FeCl₂(C₁₉H₃₅NP₂)], and {2‐[bis(diisopropylphosphanyl)methyl]‐6‐methylpyridine‐κ²P ,N }dichloridocobalt(II), [CoCl₂(C₁₉H₃₅NP₂)], the ligand adopts a bidentate P ,N‐coordination, whereas in the case of the octahedral Mn complex {2‐[bis(diisopropylphosphanyl)methyl]‐6‐methylpyridine‐κ²P ,P ′}bromidotricarbonylmanganese(I), [MnBr(C₁₉H₃₅NP₂)(CO)₃], the ligand coordinates via both P atoms to the metal centre.     

Synthesis of 2‐Aryl‐5‐oxo‐4‐[2‐(phenylmethylidene)hydrazino]‐2,5‐dihydro‐1H‐pyrrole‐3‐carboxylates by the Reaction between Hydrazones,Acetylenedicarboxylates, and 1‐Aryl‐N,N′‐bis(arylmethylidene)methanediamines

An efficient approach for the preparation of functionalized 2‐aryl‐2,5‐dihydro‐5‐oxo‐4‐[2‐(phenylmethylidene)hydrazino]‐1H‐pyrroles is described. The four‐component reaction between aldehydes, NH₂NH₂?H₂O, dialkyl acetylenedicarboxylates, and 1‐aryl‐N,N′‐bis(arylmethylidene)methanediamines proceeds in EtOH under reflux in good‐to‐excellent yields (Scheme 1). The structures of 4 were corroborated spectroscopically (IR, ¹H‐ and ¹³C‐NMR, and EI‐MS, and, in the case of 4f , by X‐ray crystallography). A plausible mechanism for this type of reaction is proposed (Scheme 2).     

Synthesis and Biological Activities of 7‐Arylazo‐7H‐pyrazolo[5,1‐c][1,2,4] Triazol‐6(5H)‐Ones and 7‐Arylhydrazono‐7H‐[1,2,4]triazolo[3,4‐b] [1,3,4]thiadiazines

Two series of 7‐arylazo‐7H‐3‐(2‐methyl‐1H‐indol‐3‐yl)pyrazolo[5,1‐c][1,2,4]triazol‐6(5H)‐ones 4 and 7‐arylhydrazono‐7H‐3‐(2‐methyl‐1H‐indol‐3‐yl)‐[1,2,4]triazolo[3,4‐b][1,3,4]thiadiazines 7 were prepared via reactions of 4‐amino‐3‐mercapto‐5‐(2‐methyl‐1H‐indol‐3‐yl)‐1,2,4‐triazole 1 with ethyl arylhydrazono‐chloroacetate 2 and N‐aryl‐2‐oxoalkanehydrazonoyl halides 5 , respectively. A possible mechanism is proposed to account for the formation of the products. The biological activity of some of these products was also evaluated.